
Press Releases
December 13, 2017
Dicerna Public Offering of Common Stock
Alexandria Real Estate Equities, Inc. Declares Quarterly Cash Dividend of 90 Cents per Common Share up 4 Cents, or 5 Percent, over 3Q17
December 4, 2017
November 29, 2017
Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock
November 28, 2017
CollPlant Receives Substantial, Repeat Order for its Biological Ink
November 28, 2017
Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock
November 28, 2017
Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent
November 22, 2017
Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development
November 21, 2017
Dicerna to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference
November 21, 2017
Nevakar Announces First Subject Dosed in its Phase 3 Clinical Trial of NVK-002 for the Treatment of Myopia in Children
November 9, 2017
Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes
November 8, 2017
Ophthotech Reports Third Quarter 2017 Financial and Operating Results
November 8, 2017
Dicerna to Present at the Stifel 2017 Healthcare Conference
November 7, 2017
Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th
October 30, 2017
Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2017, Financial and Operating Results; Strong Internal and External Growth and
Significant Near-Term Contractual Rent Growth
October 30, 2017
Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2017, Financial and Operating Results; Strong Internal and External Growth and
Significant Near-Term Contractual Rent Growth
October 30, 2017
Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017
October 26, 2017
Dicerna to Report Third Quarter 2017 Financial Results and Host Conference Call on November 2, 2017
October 16, 2017
Dicerna Files Clinical Trial Application for DCR-PHXC, the Company’s Most Advanced GalXC™ Product Candidate, for Phase 1 Study in Primary Hyperoxaluria (PH)
October 3, 2017
Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separation
October 2, 2017
Nanotherapeutics Announces Name Change to Ology Bioservices, Reflecting the Company’s Ongoing Transformation into One of the Top Contract Development and Manufacturing Organizations of Vaccines and Biologics
September 27, 2017
Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa
September 25, 2017
Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2017 Operating and Financial Results Conference Call and Webcast on October 31, 2017
September 25, 2017
Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017
September 20, 2017
Dicerna to Participate in Fireside Chat at the LEERINK Partners Roundtable Series
September 19, 2017
Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update
September 19, 2017
Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases
September 13, 2017
Alexandria Real Estate Equities, Inc. Recognized for Leadership in Sustainability, One of Its Core Pillars, Earning GRESB Green Star and #1 Ranking in the U.S. in Health & Well-Being Module
September 12, 2017
Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on September 19, 2017
September 11, 2017
Alexandria Real Estate Equities, Inc. Continues to Enhance Its Critical Support of the U.S. Military with Creation of New Headquarters for The Honor Foundation in San Diego, in Partnership with the Navy SEAL Foundation
September 7, 2017
Cerus Endovascular Provides Corporate Update
September 6, 2017
Alexandria Real Estate Equities, Inc. Declares Quarterly Cash Dividend of 86 Cents per Common Share Up 6 Cents, or 8 Percent, over 3Q16
September 5, 2017
Alexandria Real Estate Equities, Inc. Announces Completion of 100% Pre-Leasing at 100 Binney Street in Cambridge, MA, Ahead of Delivery in 4Q17
September 5, 2017
Dicerna to Present at Rodman & Renshaw 19th Annual Global Investment Conference
September 5, 2017
CollPlant in Advanced Negotiations for US Private Placement of USD 5.0 Million Agreement Includes Plan for NASDAQ Uplisting
September 5, 2017
Cesca Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
August 31, 2017
Cesca Therapeutics to Participate in the CAR-TCR Summit 2017
August 24, 2017
Cesca Therapeutics Announces International Distribution Agreement with Boyalife WSN LTD.
August 14, 2017
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration
August 10, 2017
Dicerna Reports Second Quarter 2017 Financial and Operating Results and Provides Corporate Update
August 3, 2017
Dicerna to Report Second Quarter 2017 Financial Results and Host Conference Call on August 10, 2017
July 31, 2017
Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2017, Financial and Operating Results Strong Internal and External Growth
July 28, 2017
Cesca Therapeutics Announces Issuance of New Cellular Processing Patent Poised to Revolutionize CAR-T Cell Manufacturing
July 26, 2017
Ophthotech Reports Second Quarter 2017 Financial and Operating Results
July 26, 2017
Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases
July 17, 2017
Dicerna Expands Lead GalXCâ„¢ Development Program to Encompass All Forms of Primary Hyperoxaluria (PH) and Reveals New Therapeutic Target for DCR-PHXC
July 11, 2017
MAXIMUS Declares Quarterly Cash Dividend of $0.045 per Share
July 10, 2017
Cesca Therapeutics Acquires the Cell Processing Systems of Syngen Under Asset Acquisition Agreement
July 7, 2017
Alexandria Real Estate Equities, Inc. to Hold Its Second Quarter 2017 Operating and Financial Results Conference Call and Webcast on August 1, 2017
July 6, 2017
Cerus Endovascular Receives CE Mark Approval for the Contour Neurovascular Systemâ„¢ for the Treatment of Intra-Cranial Aneurysms
July 6, 2017
Alexandria Real Estate Equities, Inc. Elects Michael A. Woronoff to Board of Directors
July 5, 2017
Alexandria Real Estate Equities, Inc. Announces the Alexandria Center for AgTech – RTP, Initial Phase of First Multi-Tenant, Amenity-Rich Mega R&D Campus with Greenhouses at Epicenter of Research Triangle Park, NC
June 23, 2017
Cesca Therapeutics Set to Join Russell Microcap Index
June 22, 2017
Robert J. Hennessey Appointed Chairman of the Board of Nanotherapeutics
June 21, 2017
Vigilant Biosciences Announces Further Clinical Data in Support of its OncAlert® Oral Cancer Product Line at IFOS ENT World Congress 2017 Symposium and at Annual MASCC Meeting
June 20, 2017
Peter H. Khoury, Ph.D., MBA Appointed President and Chief Executive Officer of Nanotherapeutics
June 13, 2017
Alexandria LaunchLabs, NYC’s Premier Life Science Startup Platform, Celebrates Grand Opening and Awards Inaugural $100,000 Entrepreneurship Prize
June 12, 2017
Cesca Therapeutics to Present at the 2017 Marcum Microcap Conference
June 8, 2017
Dicerna Announces Appointment of Ralf Rosskamp, M.D., as Chief Medical Officer
June 1, 2017
Dicerna to Present at Jefferies 2017 Global Healthcare Conference
May 22, 2017
Alexandria Real Estate Equities, Inc. to Ring The Opening Bell to Celebrate Its 20th Anniversary as a New York Stock Exchange Listed REIT
May 21, 2017
CollPlant Extends its European Distribution Network with Signing of New Distribution Agreement in Turkey for Vergenix® FG Wound Treatment
May 18, 2017
Cesca Therapeutics to Present at the Inaugural Cell and Gene Exchange 2017
May 9, 2017
Semler Reports First Quarter 2017 Financial Results
May 8, 2017
CDR-Life Announces Formation of Scientific Advisory Board
May 8, 2017
Dicerna Reports First Quarter 2017 Financial and Operational Results and Provides Corporate Update
May 4, 2017
Admedus Releases Results of HSV-2 Phase lla Study
May 2, 2017
Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic
May 2, 2017
Admedus Receives FDA Clearance for Cardiocel 3D
May 2, 2017
Cesca to Exhibit at the 25th International Society for Cellular Therapy (ISCT) Annual Meeting
May 1, 2017
Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2017, Financial and Operating Results Strong Internal and External Growth
May 1, 2017
Dicerna to Report First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017
April 27, 2017
Pendant Biosciences Announces Acceptance into JLABS @ Toronto
Rx Communications Group, LLC